Cargando…
Antiplasmodial activity, in vivo pharmacokinetics and anti-malarial efficacy evaluation of hydroxypyridinone hybrids in a mouse model
BACKGROUND: During the erythrocytic stage in humans, malaria parasites digest haemoglobin of the host cell, and the toxic haem moiety crystallizes into haemozoin. Chloroquine acts by forming toxic complexes with haem molecules and interfering with their crystallization. In chloroquine-resistant stra...
Autores principales: | Dambuza, Ntokozo S., Smith, Peter, Evans, Alicia, Norman, Jennifer, Taylor, Dale, Andayi, Andrew, Egan, Timothy, Chibale, Kelly, Wiesner, Lubbe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4681141/ https://www.ncbi.nlm.nih.gov/pubmed/26671222 http://dx.doi.org/10.1186/s12936-015-1032-5 |
Ejemplares similares
-
A Pharmacokinetic Study of Antimalarial 3,5-Diaryl-2-aminopyridine Derivatives
por: Dambuza, Ntokozo, et al.
Publicado: (2015) -
Efficacy and pharmacokinetic evaluation of a novel anti-malarial compound (NP046) in a mouse model
por: Abay, Efrem T, et al.
Publicado: (2015) -
Potent in vivo anti-malarial activity and representative snapshot pharmacokinetic evaluation of artemisinin-quinoline hybrids
por: Lombard, Marli C, et al.
Publicado: (2013) -
The development and validation of an LC-MS/MS method for the determination of a new anti-malarial compound (TK900D) in human whole blood and its application to pharmacokinetic studies in mice
por: Abay, Efrem T, et al.
Publicado: (2014) -
Discovery of Novel Cyclic Ethers with Synergistic Antiplasmodial Activity in Combination with Valinomycin
por: Watson, Daniel J., et al.
Publicado: (2021)